Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-09-23
1990-10-30
Teskin, Robin L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530398, 530399, 530350, 435 701, 435 703, 514 8, 514 12, 424 88, A61K 3700, A61K 3738, A61K 3729, A61K 3736
Patent
active
049668889
ABSTRACT:
Purified hCG-hLH receptor, hCG-hLH receptor-hCG complex and combinations between their subunits as antigens, as well as antibodies thereto which are useful as a contraceptive vaccine.
REFERENCES:
patent: 4016250 (1977-04-01), Saxena
patent: 4161519 (1979-07-01), Talwar
patent: 4310455 (1982-01-01), Bahl
patent: 4560649 (1985-12-01), Satena et al.
Satena, Brij, Methods Mol. Biol., vol. 9, pt. 1, pp. 251-299, 1976 (see pp. 275-280 especially).
Rathnam Premila
Saxena Brij B.
Singh Mukul
Cornell Research Foundation Inc.
Teskin Robin L.
LandOfFree
hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and hCG-hLH receptor and hCG-hLH receptor-hCG complex as antigens, a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-275340